$7.21 Billion is the total value of C WorldWide Group Holding A/S's 171 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 24.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KO | Buy | COCA COLA CO | $334,692,000 | +882.6% | 7,630,919 | +873.0% | 4.64% | +788.0% |
| HDB | Buy | HDFC BANK LTD | $175,171,000 | +17.0% | 1,667,974 | +10.0% | 2.43% | +5.7% |
| PG | New | PROCTER AND GAMBLE CO | $113,258,000 | – | 1,450,915 | +100.0% | 1.57% | – |
| IBN | Buy | ICICI BK LTDadr | $43,628,000 | -7.3% | 5,433,100 | +2.1% | 0.60% | -16.3% |
| MRK | Buy | MERCK & CO INC | $20,028,000 | +83.1% | 329,955 | +64.3% | 0.28% | +65.5% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $12,120,000 | -17.7% | 794,747 | +7.1% | 0.17% | -25.7% |
| MYL | Buy | MYLAN N V | $11,950,000 | +4.8% | 330,668 | +19.4% | 0.17% | -5.1% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $10,968,000 | +39.0% | 64,530 | +33.3% | 0.15% | +25.6% |
| INSM | Buy | INSMED INC | $9,719,000 | +15.8% | 410,954 | +10.3% | 0.14% | +4.7% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $9,177,000 | +84.1% | 69,427 | +3.2% | 0.13% | +64.9% |
| HRTX | Buy | HERON THERAPEUTICS INC | $8,198,000 | +160.5% | 211,012 | +85.1% | 0.11% | +137.5% |
| DXCM | Buy | DEX INC | $7,656,000 | +63.4% | 80,603 | +27.6% | 0.11% | +47.2% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $7,487,000 | +89.7% | 110,838 | +52.4% | 0.10% | +70.5% |
| HZNP | Buy | HORIZON PHARMA PLC | $6,880,000 | +72.3% | 415,485 | +47.7% | 0.10% | +55.7% |
| NVCR | Buy | NOVOCURE LTD | $6,672,000 | +81.8% | 213,153 | +26.6% | 0.09% | +66.1% |
| EXAS | Buy | EXACT SCIENCES CORP | $6,738,000 | +88.4% | 112,699 | +27.1% | 0.09% | +69.1% |
| ALKS | New | ALKERMES PLC | $6,646,000 | – | 161,466 | +100.0% | 0.09% | – |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $6,635,000 | +69.1% | 246,749 | +100.1% | 0.09% | +53.3% |
| XENT | Buy | INTERSECT ENT INC | $6,345,000 | +45.4% | 169,435 | +52.6% | 0.09% | +31.3% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $5,574,000 | +84.3% | 147,587 | +59.4% | 0.08% | +67.4% |
| CARA | Buy | CARA THERAPEUTICS INC | $5,553,000 | +93.6% | 289,950 | +25.1% | 0.08% | +75.0% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $5,469,000 | -15.6% | 536,128 | +7.6% | 0.08% | -23.2% |
| KTWO | Buy | K2M GROUP HLDGS INC | $5,346,000 | +51.0% | 237,603 | +27.1% | 0.07% | +37.0% |
| LHCG | New | LHC GROUP INC | $5,021,000 | – | 58,667 | +100.0% | 0.07% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $4,934,000 | – | 385,446 | +100.0% | 0.07% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $4,838,000 | +266.8% | 242,251 | +221.9% | 0.07% | +235.0% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $4,445,000 | +53.4% | 31,858 | +23.9% | 0.06% | +40.9% |
| DERM | Buy | DERMIRA INC | $4,431,000 | +358.7% | 481,670 | +298.4% | 0.06% | +306.7% |
| ONCE | Buy | SPARK THERAPEUTICS INC | $4,270,000 | +53.5% | 51,596 | +23.5% | 0.06% | +37.2% |
| AXDX | New | ACCELERATE DIAGNOSTICS INC | $4,110,000 | – | 184,310 | +100.0% | 0.06% | – |
| TSRO | Buy | TESARO INC | $3,819,000 | +2687.6% | 85,872 | +3490.0% | 0.05% | +2550.0% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $3,820,000 | +135.1% | 64,585 | +170.4% | 0.05% | +112.0% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $3,740,000 | +95.4% | 267,157 | +54.2% | 0.05% | +79.3% |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $3,536,000 | – | 148,244 | +100.0% | 0.05% | – |
| ACHC | Buy | ACADIA HEALTHCARE PANY IN | $3,535,000 | +80.4% | 86,405 | +72.8% | 0.05% | +63.3% |
| STML | Buy | STEMLINE THERAPEUTICS INC | $3,430,000 | +31.9% | 213,706 | +25.7% | 0.05% | +20.0% |
| NEO | Buy | NEOGENOMICS INC | $3,142,000 | +100.9% | 239,681 | +25.1% | 0.04% | +83.3% |
| INCY | Buy | INCYTE CORP | $3,070,000 | -0.1% | 45,826 | +24.3% | 0.04% | -8.5% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $3,069,000 | +6.1% | 173,656 | +26.4% | 0.04% | -2.3% |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $2,880,000 | +76.7% | 38,070 | +23.1% | 0.04% | +60.0% |
| KMPH | Buy | KEMPHARM INC | $2,600,000 | -15.1% | 399,999 | +3.2% | 0.04% | -23.4% |
| PODD | Buy | INSULET CORP | $2,528,000 | +22.8% | 29,495 | +24.2% | 0.04% | +9.4% |
| CCI | New | CROWN CASTLE INTL CORP NEW | $2,146,000 | – | 19,900 | +100.0% | 0.03% | – |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $2,115,000 | +29.7% | 164,073 | +25.2% | 0.03% | +16.0% |
| ELGX | Buy | ENDOLOGIX INC | $2,063,000 | +63.7% | 364,464 | +22.3% | 0.03% | +52.6% |
| VCRA | New | VOCERA MUNICATIONS INC | $2,057,000 | – | 68,804 | +100.0% | 0.03% | – |
| BKI | New | BLACK KNIGHT INC | $2,035,000 | – | 38,000 | +100.0% | 0.03% | – |
| PFNX | Buy | PFENEX INC | $1,964,000 | +62.6% | 363,068 | +80.4% | 0.03% | +42.1% |
| ANTM | Buy | ANTHEM INC | $1,753,000 | +59.7% | 7,364 | +47.3% | 0.02% | +41.2% |
| AY | Buy | ATLANTICA YIELD PLC | $1,673,000 | +42.6% | 82,902 | +38.4% | 0.02% | +27.8% |
| PGR | Buy | PROGRESSIVE CORP OHIO | $1,236,000 | +89.3% | 20,904 | +95.0% | 0.02% | +70.0% |
| ARMK | New | ARAMARK | $1,202,000 | – | 32,407 | +100.0% | 0.02% | – |
| SBPH | Buy | SPRING BK PHARMACEUTICALS IN | $1,085,000 | -19.2% | 91,567 | +4.9% | 0.02% | -28.6% |
| SCI | New | SERVICE CORP INTL | $1,072,000 | – | 29,978 | +100.0% | 0.02% | – |
| OBLN | Buy | OBALON THERAPEUTICS INC | $679,000 | -20.2% | 315,790 | +27.3% | 0.01% | -30.8% |
| VLRX | Buy | VALERITAS HLDGS INC | $424,000 | -36.4% | 316,194 | +28.0% | 0.01% | -40.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 37 | Q3 2023 | 15.5% |
| THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
| HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
| ICICI BK LTD | 37 | Q3 2023 | 2.1% |
| CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
| DEX INC | 37 | Q3 2023 | 0.5% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
| VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
| INSULET CORP | 37 | Q3 2023 | 0.3% |
| CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-03 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.